AQVESME

mitapivat · Agios Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for AQVESME, covering 2022-02-17 to 2025-12-23. Get the full timeline:

Most recent: FDA Approved: AQVESME — Supplemental Application (Agios Pharmaceuticals, Inc.)